An Israeli Company Claims That They Will Have A Cure For Cancer In A Year. Don't Believe Them.
An Israeli company claims that they will have a cure for all cancers in a year. Here's why you shouldn't believe them. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - January 30, 2019 Category: Pharmaceuticals Authors: Victoria Forster, Contributor Source Type: news

FDA back-channel allows drug companies to transform common supplements into expensive prescription drugs
(Natural News) The depths of corruption within federal agencies know no bounds: A backchannel at the FDA has given Big Pharma the ability to turn ordinary nutritional supplements into expensive medications and treatments — and also gives drug companies the ability to file requests that ultimately lead to the supplement version being removed from the... (Source: NaturalNews.com)
Source: NaturalNews.com - January 30, 2019 Category: Consumer Health News Source Type: news

More infant ibuprofen recalled over fears it contains dangerously high levels of the drug
The drug made by Tris Pharma, sold by three different brands, is meant to contain 50mg of ibuprofen per 1.25 ml. But routine tests found some units contained 10 percent more. (Source: the Mail online | Health)
Source: the Mail online | Health - January 30, 2019 Category: Consumer Health News Source Type: news

Can Digital Medicine Improve Drug Adherence?
A new digital health program focused on oncology patients is attempting to improve outcomes using a risk-shared payment structure between a health system and Silicon Valley company (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - January 30, 2019 Category: Pharmaceuticals Authors: Greg Licholai, Contributor Source Type: news

Malnutrition In Hospitals Linked To Greater Risk Of Death, Study Finds
A new study now sheds light on the importance of proper nutrition in hospitalized patients, linking it to their survival. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - January 30, 2019 Category: Pharmaceuticals Authors: Robert Glatter, MD, Contributor Source Type: news

Magnolia Medical Announces $20 Million Series C Financing
Funding to accelerate company mission to establish new standard of care in sepsis testing accuracy SEATTLE, Jan. 30, 2019 -- (Healthcare Sales & Marketing Network) -- Magnolia Medical Technologies today announced a $20 million Series C financing round ... Devices, Venture Capital, Personnel Magnolia Medical Technologies, Steripath, Specimen Diversion Device (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 30, 2019 Category: Pharmaceuticals Source Type: news

CardioVax Announces Name Change to Abcentra
Reflects Strategic Commitment to a Novel Drug Target for Inflammatory Disease LOS ANGELES, Jan. 30, 2019 -- (Healthcare Sales & Marketing Network) -- CardioVax, a privately held, clinical-stage biopharmaceutical company developing novel antibody therap... Biopharmaceuticals Abcentra, CardioVax, low-density lipoprotein (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 30, 2019 Category: Pharmaceuticals Source Type: news

ArcherDX Acquires Baby Genes, a Genetics-Based Personalized Medicine Company
BOULDER, Colo., Jan. 30, 2019 -- (Healthcare Sales & Marketing Network) -- ArcherDX, Inc., a molecular technology company dedicated to developing breakthrough solutions that advance the application of personalized genomic medicine, is pleased to announce ... Diagnostics, Mergers & Acquisitions ArcherDX, Baby Genes, Anchored Multiplexed PCR, PCR (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 30, 2019 Category: Pharmaceuticals Source Type: news

Baylis Strengthens Global Commercialization Strategy with Senior Hire
TORONTO, Jan. 30, 2019 -- (Healthcare Sales & Marketing Network) - Baylis Medical is pleased to announce that seasoned marketing executive Gloria Yee has joined Baylis as its Vice President of Marketing. In her role, Gloria will be instrumental in expandi... Devices, Interventional, Cardiology, Personnel Baylis Medical (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 30, 2019 Category: Pharmaceuticals Source Type: news

After Theranos, Healthcare Startups Still Aren ’t Publishing Enough Peer-Reviewed Research, Says One Stanford Professor. Venture Capitalists Disagree.
Without published research, scientists and prospective investors and customers have little to go on to evaluate a startup's marketing claims, the Stanford team maintains. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - January 30, 2019 Category: Pharmaceuticals Authors: Ellie Kincaid, Forbes Staff Source Type: news

Anthem To Launch PBM Earlier, Ending Express Scripts Deal In March
Anthem will move up the launch of its pharmacy benefit management (PBM) company IngenioRx, saying it will begin transitioning members away from Express Scripts in less than two months. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - January 30, 2019 Category: Pharmaceuticals Authors: Bruce Japsen, Contributor Tags: NYSE:UNH NASDAQ:ESRX NYSE:CVS NYSE:ANTM NYSE:CI Source Type: news

Janssen Announces ERLEADA ® (apalutamide) Phase 3 TITAN Study Unblinded as Dual Primary Endpoints Achieved in Clinical Program Evaluating Treatment of Patients with Metastatic Castration-Sensitive Prostate Cancer
(Source: Johnson and Johnson)
Source: Johnson and Johnson - January 30, 2019 Category: Pharmaceuticals Source Type: news

Alternatives To Obamacare
The four top “sharing” organizations now insure more than one million people. To put that in perspective, only about 10 million people are currently enrolled in Obamacare exchanges. There may be more who have an alternative (non-ACA-compliant) plan than those with an unsubsidized Obamacare plan. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - January 30, 2019 Category: Pharmaceuticals Authors: John C. Goodman, Contributor Source Type: news

Humana makes two changes in its management team
Humana Inc. has made two new appointments to its management team. The Louisville-based health care and health plan company promoted Joseph Ventura to general counsel and named Douglas Stoss interim lead for Humana’s Office of Corporate Affairs. Both will report to Humana President and CEO Bruce Broussard and serve as members of the company’s management team , according to a news release. Ventura succeeds Christopher Todoroff, who is retiring after a three-decade career in corporate law, including… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - January 30, 2019 Category: Pharmaceuticals Authors: Carolyn Tribble Greer Source Type: news

ASA: Flu-Like Illness Linked to Increased Risk for Stroke
WEDNESDAY, Jan. 30, 2019 -- Influenza-like illness (ILI) is associated with an increased risk for ischemic stroke and cervical artery dissection (CeAD), according to two studies presented at the American Stroke Association International Stroke... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 30, 2019 Category: Pharmaceuticals Source Type: news

More Severe Injuries Sustained at Jump Parks Versus Home Trampolines
WEDNESDAY, Jan. 30, 2019 -- The proportion of fractures/dislocations, lower-extremity fractures, fractures in adults, and surgical interventions is higher for injuries associated with jump parks versus home trampolines, according to a study... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 30, 2019 Category: Pharmaceuticals Source Type: news

Avoiding Full-Blown Diabetes Cuts Cardiovascular Risk
WEDNESDAY, Jan. 30, 2019 -- Midlife increases in fasting glucose (FG) with conversion to diabetes are associated with higher cardiovascular disease (CVD) risk, according to research published online Jan. 7 in Diabetes Care. Michael P. Bancks, Ph.D.,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 30, 2019 Category: Pharmaceuticals Source Type: news

Thymectomy & #43; PDN Beneficial for Non-Thymomatous Myasthenia Gravis
WEDNESDAY, Jan. 30, 2019 -- For patients with non-thymomatous myasthenia gravis, thymectomy plus prednisone confers benefits versus prednisone alone at five years, according to a study published online Jan. 25 in The Lancet Neurology. Gil I. Wolfe,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 30, 2019 Category: Pharmaceuticals Source Type: news

Hand Hygiene Compliance Low Among EMS Providers
WEDNESDAY, Jan. 30 2019 -- Among emergency medical service (EMS) providers, compliance with hand hygiene (HH) is low, according to a study published online Jan. 28 in the Emergency Medical Journal. Heidi Storm Vikke, Ph.D., from the University of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 30, 2019 Category: Pharmaceuticals Source Type: news

Undisturbed Maternal Sleep Tied to Higher Risk for Late Stillbirth
WEDNESDAY, Jan. 30, 2019 -- Long periods of undisturbed sleep during pregnancy are associated with late stillbirth, according to a study published online Jan. 18 in Birth. Louise M. O'Brien Ph.D., from Michigan Medicine in Ann Arbor, and colleagues... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 30, 2019 Category: Pharmaceuticals Source Type: news

ASA: Increased Odds of Stroke, MI With E-Cigarette Use
WEDNESDAY, Jan. 30, 2019 -- Electronic cigarette use is associated with increased odds of stroke, myocardial infarction, and angina or coronary heart disease, according to a study presented at the American Stroke Association International Stroke... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 30, 2019 Category: Pharmaceuticals Source Type: news

Off-Label Uses in Dermatology Often Missing From Compendia
WEDNESDAY, Jan. 30, 2019 -- The compendia used by Medicare for making coverage determinations are inadequate for dermatologic illnesses, and there is considerable discrepancy between compendia, according to a study published online Jan. 23 in JAMA... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 30, 2019 Category: Pharmaceuticals Source Type: news

Patient Attitude Tied to Physical Therapy Outcomes
WEDNESDAY, Jan. 30, 2019 -- Patient expectation and pain self-efficacy are associated with clinical outcomes among patients undergoing physical therapy for shoulder pain, according to a study published online Jan. 24 in the British Journal of Sports... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 30, 2019 Category: Pharmaceuticals Source Type: news

No Asthma Benefit Seen With n3PUFA in Overweight Teens
WEDNESDAY, Jan. 30, 2019 -- Omega-3 fatty acid (n3PUFA) supplements do not appear to improve asthma control in teens and young adults who are overweight or obese, according to a study published online Jan. 25 in the Annals of the American Thoracic... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 30, 2019 Category: Pharmaceuticals Source Type: news

Researchers call for big data infrastructure to support future of personalized medicine
Researchers from the George Washington University (GW), the U.S. Food and Drug Administration (FDA), and industry leaders published in PLOS Biology, describing a standardized communication method for researchers performing high-throughput sequencing (HTS) called BioCompute. (Source: World Pharma News)
Source: World Pharma News - January 30, 2019 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Not Approved: State regulators deny UNC, Duke, WakeMed applications to expand surgical centers
The N.C. Department of Health and Human Services issued a surprise decision Tuesday, denying all of the competing applications to build operating centers by Triangle ’s largest health care providers. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - January 30, 2019 Category: Pharmaceuticals Authors: Seth Thomas Gulledge Source Type: news

Merck Granted U.S. Patent for novel combination of Artificial Intelligence and Blockchain Technology
Merck, a leading science and technology company, today announced that it has been granted Patent No. US 10,193,695 by the United States Patent and Trademark Office (USPTO). The patent relates to the formation of 'crypto-objects', a novel security procedure linking Artificial Intelligence (AI) and blockchain technology. (Source: World Pharma News)
Source: World Pharma News - January 30, 2019 Category: Pharmaceuticals Tags: Featured Merck Group Business and Industry Source Type: news

Novartis forecasts mid-single digit sales growth in 2019
Chief executive expects 10 ‘blockbuster’ launches by 2020 (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - January 30, 2019 Category: Pharmaceuticals Source Type: news

Roche to discontinue Phase III CREAD 1 and 2 clinical studies of crenezumab in early Alzheimer ’s disease (AD) - other company programmes in AD continue
- Roche today announced the decision to discontinue CREAD I and CREAD 2 (BN29552 and BN29553) Phase III studies of the investigational anti-beta-amyloid molecule crenezumab in people with early (prodromal to mild) sporadic Alzheimer ’s disease (AD). The decision was based on the results of a pre-planned interim analysis assessing the safety and efficacy of crenezumab conducted by the Independent Data Monitoring Committee, which indicated that crenezumab was unlikely to meet the primary endpoint of change from baseline in Clin ical Dementia Rating-Sum of Boxes (CDR-SB) Score. No safety signals for crenezumab were obse...
Source: Roche Investor Update - January 30, 2019 Category: Pharmaceuticals Source Type: news

Roche to discontinue Phase III CREAD 1 and 2 clinical studies of crenezumab in early Alzheimer ’s disease (AD) - other company programmes in AD continue
- Roche today announced the decision to discontinue CREAD I and CREAD 2 (BN29552 and BN29553) Phase III studies of the investigational anti-beta-amyloid molecule crenezumab in people with early (prodromal to mild) sporadic Alzheimer ’s disease (AD). The decision was based on the results of a pre-planned interim analysis assessing the safety and efficacy of crenezumab conducted by the Independent Data Monitoring Committee, which indicated that crenezumab was unlikely to meet the primary endpoint of change from baseline in Clin ical Dementia Rating-Sum of Boxes (CDR-SB) Score. No safety signals for crenezumab were obse...
Source: Roche Media News - January 30, 2019 Category: Pharmaceuticals Source Type: news

Social Media And Loneliness: More Research Is Finding A Connection, But Big Questions Remain
New research adds to a list of studies finding a link between social media use and feelings of loneliness. How to interpret the results, however, is anything but crystal clear. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - January 30, 2019 Category: Pharmaceuticals Authors: David DiSalvo, Contributor Source Type: news

Funds stock up on Chinese staples and healthcare stocks
Buying spree comes as managers dump Turkish financials and Russian consumer companies (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - January 30, 2019 Category: Pharmaceuticals Source Type: news

Israeli Scientists Say They Will Have A Complete Cure For Cancer Within A Year
“We believe we will offer in a year’s time a complete cure for cancer,” said Dan Aridor, chairman of the board of Accelerated Evolution Biotechnologies Ltd. (AEBi). (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - January 30, 2019 Category: Pharmaceuticals Authors: Robin Seaton Jefferson, Contributor Source Type: news

Ambry Genetics and Undiagnosed Diseases Network Team Up to Offer Hope...
Collaboration holds promise to patients in search for answers and an end to their diagnostic odyssey(PRWeb January 30, 2019)Read the full story at https://www.prweb.com/releases/ambry_genetics_and_undiagnosed_diseases_network_team_up_to_offer_hope_for_patients_with_undiagnosed_diseases/prweb16067927.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - January 30, 2019 Category: Pharmaceuticals Source Type: news

LaunchBio's Invest in Cures Forum February 13 Offers Insights,...
Representatives from 10 Disease Foundations to Discuss Investment Strategy at NY Stem Cell Foundation(PRWeb January 30, 2019)Read the full story at https://www.prweb.com/releases/launchbio_s_invest_in_cures_forum_february_13_offers_insights_connections_into_impact_investing_in_healthcare/prweb16065078.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - January 30, 2019 Category: Pharmaceuticals Source Type: news

Visikol to Present Three Talks at SLAS Highlighting 3D Cell Culture...
As a leading provider of 3D cell culture assay services, Visikol will be hosting several talks at SLAS this year where it will highlight its unique assay service offering.(PRWeb January 30, 2019)Read the full story at https://www.prweb.com/releases/visikol_to_present_three_talks_at_slas_highlighting_3d_cell_culture_assay_services/prweb16054196.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - January 30, 2019 Category: Pharmaceuticals Source Type: news

Strides to exit investment in Arrow for AUD 394 million
In a separate filing, the company said its step-down subsidiary Strides Pharma Inc has entered into an arrangement to acquire 100 per cent stake in US-based generics company Vensun Pharmaceuticals Inc. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 30, 2019 Category: Pharmaceuticals Source Type: news

Natco dares Novartis with new heart drug
According to data from AIOCD PharmaTrac, an agency that closely tracks pharmaceutical sales, Vymada had sales of Rs 68.3 crore for December 2018 on the moving annual turnover (MAT). (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 30, 2019 Category: Pharmaceuticals Source Type: news

How ironic: Long-term painkiller use makes you more sensitive to pain
(Natural News) The United States has been deeply entrenched in the opioid epidemic for years. Dozens of cities, counties and states have filed suit against a number of the nation’s top pharmaceutical industry for their role in creating a drug epidemic which has destroyed thousands of families and claimed thousands of lives. Big Pharma has... (Source: NaturalNews.com)
Source: NaturalNews.com - January 29, 2019 Category: Consumer Health News Source Type: news

Pfizer and Lilly osteoarthritis pain drug grabs another win
The pair of drugmakers announced that its drug tanezumab reduced pain significantly at the higher of two doses tested, with a phase 3 trial from last year also showing efficacy (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - January 29, 2019 Category: Pharmaceuticals Source Type: news

Takeda to sell 21 assets, including Osaka headquarters
The Japanese drugmaker plans to sell off the buildings in March in order to pare down the debt stemming from the $62 billion acquisition of Shire (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - January 29, 2019 Category: Pharmaceuticals Source Type: news

Fitness Recovery Tech: What Is Cryotherapy, What Are The Benefits, And How Does It Work?
I gave cryotherapy a try to see if the latest innovation in fitness recovery actually works (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - January 29, 2019 Category: Pharmaceuticals Authors: Lee Bell, Contributor Source Type: news

Amgen Reports Fourth Quarter And Full Year 2018 Financial Results
THOUSAND OAKS, Calif., Jan. 29, 2019 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced financial results for the fourth quarter and full year 2018 in comparison to comparable periods in 2017. Key results include: For the fourth quarter, total revenues increased 7 percent to $6.2 billion. Product sales grew 8 percent globally. New and recently launched products including Repatha® (evolocumab), Prolia® (denosumab), KYPROLIS® (carfilzomib) and XGEVA® (denosumab) showed double-digit growth. For the full year, total revenues increased 4 percent to $23.7 billion, with 3 percent product s...
Source: Amgen News Release - January 29, 2019 Category: Pharmaceuticals Tags: Uncategorized Source Type: news

Another Reason to Update Your Biocompatibility Approach: EU MDRs
Medtech companies have been working for a couple years to update their approach to biocompatibility testing in preparation for the new ISO 10993-1, “Biological evaluation of medical devices -- Part 1: Evaluation and testing within a risk management process,” which became official last August 2018. But there may be an even more compelling reason to get up to speed on the new standard—the European Union’s new Medical Device Regulations (MDRs). “We’ve been talking about ISO 10993-1 changes for some time&acir...
Source: MDDI - January 29, 2019 Category: Medical Devices Authors: Daphne Allen Tags: Testing Source Type: news

Allergan worst performer on S&P 500 after weak outlook
Botox maker also shelved plans to sell its women’s health business (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - January 29, 2019 Category: Pharmaceuticals Source Type: news

Confederated Tribes of Warm Springs seeks damages from opioid makers
Add the Confederated Tribes of Warm Springs to the very long list of plaintiffs suing Purdue Pharma and other opioid producers in connection with the epidemic of abuse “devastating the United States,” according to the tribe's lawsuit filed in U.S. District Court in Portland. “Indian Country has been particularly hard hit,” the suit says, causing the Confederated Tribes to “suffer substantial loss of resources, economic damages and damages to the health and welfare of its members.” The… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - January 29, 2019 Category: Biotechnology Authors: Elizabeth Hayes Source Type: news

Benefits, Barriers to Exercise Examined for Patients With ESKD
TUESDAY, Jan. 29, 2019 -- Patients with end-stage kidney disease (ESKD) undergoing maintenance dialysis express a desire to exercise to regain energy and strength, but many report barriers to exercise, according to a study published online Jan. 29... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 29, 2019 Category: Pharmaceuticals Source Type: news

9/11 Responders May Have Higher Head, Neck Cancer Risk
TUESDAY, Jan. 29, 2019 -- There may be a significant, emerging risk for human papillomavirus (HPV)-related head and neck cancers (HNC) among workers and volunteers who responded to the 9/11 terrorist attacks on the World Trade Center (WTC),... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 29, 2019 Category: Pharmaceuticals Source Type: news

Large Insulin Price Hike to Be Investigated by U.S. Congress
TUESDAY, Jan. 29, 2019 -- The soaring cost of insulin will be investigated as the U.S. Congress holds hearings into the high cost of prescription drugs, a lawmaker says. " I have heard stories about people reducing their lifesaving medicines, like... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 29, 2019 Category: Pharmaceuticals Source Type: news

Prophylaxis for Gonococcal Eye Infections in Newborns Advised
TUESDAY, Jan. 29, 2019 -- The U.S. Preventive Services Task Force (USPSTF) has reaffirmed the recommendation for use of ocular prophylaxis for gonococcal ophthalmia neonatorum. This recommendation forms the basis of a final recommendation statement... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 29, 2019 Category: Pharmaceuticals Source Type: news